Department of Obstetrics and Gynecology, School of Medicine, Women's Reproductive Health Research Center, Clinical Research Institute, Alzahra Hospital, Tabriz University of Medical sciences, Tabriz, Iran.
Department of Midwifery, Social Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
BMC Pregnancy Childbirth. 2021 May 17;21(1):378. doi: 10.1186/s12884-021-03764-y.
Physiological changes during pregnancy put pregnant women at higher risk for COVID-19 complications. The objective of this study was to evaluate clinical and laboratory characteristics and outcomes of 24 COVID-19 pregnant patients and their newborns referred to the Al-Zahra tertiary maternity hospital in Tabriz, Iran.
Clinical records of 24 COVID-19 confirmed pregnant patients were retrospectively reviewed from10 March 2020 to 15 April 2020. Vertical transition was assessed through neonatal pharyngeal swab samples. The study has been approved by the Tabriz University Medical Ethics Committee (IR.TBZMED.REC.1399.497).
There were 24 hospitalized cases with clinical symptoms and confirmed diagnosis of COVID-19. The mean age of cases was 26.5 years; most were nulliparous (54.2%), in their third trimester (62.5%) and were in the type A blood group. Clinical symptoms in order of prevalence were cough, fever, dyspnea, myalgia, anosmia, and diarrhea. Oxygen saturation (SpO2) in 70.8% cases was in the normal range (greater than 93%). The risk of premature labor or abortion in cases showed no increase. 12 cases were in ongoing normal status; on follow up, 11 cases had delivered their babies at term and one had ended in IUFD because of pregnancy-induced hypertension. All delivered babies were healthy. Caesarean section in all cases was performed under obstetric indications or maternal demand, and no relation was found between COVID-19 and Caesarean delivery. Neonatal outcomes according to gestational age in 8 cases out of 11 (72.72%) were desirable; neonatal morbidity and mortality resulted from pregnancy complications. Blood pH in 6 neonates was assessed due to immaturity and NICU admission, all of which were in normal ranges except one case related to HELLP syndrome. There was no evidence of vertical transmission.
Findings suggest that clinical symptoms in pregnancy were similar to non-pregnant women, no rise in risk of premature labor or abortion was seen, and vertical transmission was not observed in none of cases. Lymphopenia was the leading laboratory change. Given asymptomatic cases despite severe forms of infection in pregnancies, we propose screening in all suspected cases. All placentas and newborns should be tested in the field for vertical transmission.
怀孕期间的生理变化使孕妇感染 COVID-19 后出现并发症的风险更高。本研究的目的是评估 24 例 COVID-19 确诊孕妇及其在伊朗大不里士 Al-Zahra 三级妇产医院分娩的新生儿的临床和实验室特征及结局。
回顾性分析 2020 年 3 月 10 日至 4 月 15 日期间 24 例 COVID-19 确诊孕妇的临床记录。通过新生儿咽部拭子样本评估垂直传播。本研究已获得大不里士塔比兹大学医学伦理委员会的批准(IR.TBZMED.REC.1399.497)。
共有 24 例有临床症状且确诊 COVID-19 的住院病例。病例的平均年龄为 26.5 岁;大多数为初产妇(54.2%),处于孕晚期(62.5%),血型为 A 型。按发病率顺序排列的临床症状依次为咳嗽、发热、呼吸困难、肌痛、嗅觉丧失和腹泻。70.8%的病例血氧饱和度(SpO2)正常(大于 93%)。病例早产或流产的风险并未增加。12 例病情稳定;随访中,11 例足月分娩,1 例因妊娠高血压导致胎儿宫内死亡。所有分娩的婴儿均健康。所有病例均根据产科指征或产妇要求行剖宫产术,未发现 COVID-19 与剖宫产术之间的关系。11 例中 8 例(72.72%)新生儿的胎龄结果理想;新生儿发病率和死亡率是由妊娠并发症引起的。由于新生儿不成熟和入住新生儿重症监护病房,对 6 例新生儿的血 pH 值进行了评估,除 1 例与 HELLP 综合征有关的病例外,所有新生儿的 pH 值均在正常范围内。未发现垂直传播的证据。
研究结果表明,妊娠期间的临床症状与非孕妇相似,未观察到早产或流产风险增加,且无一例发生垂直传播。淋巴细胞减少是主要的实验室变化。鉴于妊娠期间存在严重感染但无症状病例,我们建议对所有疑似病例进行筛查。所有胎盘和新生儿都应在现场进行垂直传播检测。